Catalyst Financial Partners LLC Acquires 281 Shares of Colgate-Palmolive (NYSE:CL)

Catalyst Financial Partners LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 10.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,862 shares of the company’s stock after buying an additional 281 shares during the quarter. Catalyst Financial Partners LLC’s holdings in Colgate-Palmolive were worth $278,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. purchased a new position in Colgate-Palmolive during the second quarter valued at $25,000. Union Savings Bank boosted its holdings in shares of Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the last quarter. PSI Advisors LLC grew its position in shares of Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after purchasing an additional 348 shares in the last quarter. Continuum Advisory LLC increased its holdings in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $32,000. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now owns 5,146 shares in the company, valued at $529,729.24. The disclosure for this sale can be found here. Insiders have sold 41,177 shares of company stock valued at $4,245,835 in the last ninety days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Price Performance

NYSE:CL traded up $0.69 during trading hours on Monday, hitting $104.90. 1,316,589 shares of the stock were exchanged, compared to its average volume of 4,343,547. The company has a market cap of $86.06 billion, a P/E ratio of 32.98, a P/E/G ratio of 3.54 and a beta of 0.39. The firm’s fifty day moving average price is $99.21 and its 200 day moving average price is $92.97. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $105.19. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same period in the prior year, the company earned $0.77 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 1.91%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of research reports. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. TD Cowen increased their price objective on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. Royal Bank of Canada increased their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a report on Monday, April 29th. Evercore ISI boosted their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Finally, Bank of America raised their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Eight research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.